Stoke Therapeutics

About:

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

Website: https://www.stoketherapeutics.com/

Twitter/X: StokeTx

Top Investors: RA Capital Management, Alexandria Venture Investments, Perceptive Advisors, Cormorant Asset Management, RTW Investments

Description:

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment of severe genetic diseases.